Stock Analysis

Imagine Holding Arcturus Therapeutics Holdings (NASDAQ:ARCT) Shares While The Price Zoomed 820% Higher

  •  Updated
Source: Shutterstock

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. Not every pick can be a winner, but when you pick the right stock, you can win big. One such superstar is Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), which saw its share price soar 820% in three years. It's also good to see the share price up 100% over the last quarter. The company reported its financial results recently; you can catch up on the latest numbers by reading our company report.

We love happy stories like this one. The company should be really proud of that performance!

Check out our latest analysis for Arcturus Therapeutics Holdings

Arcturus Therapeutics Holdings isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

Over the last three years Arcturus Therapeutics Holdings has grown its revenue at 11% annually. That's pretty nice growth. Some shareholders might think that the share price rise of 110% per year is a lucky result, considering the level of revenue growth. After a price rise like that many will have the business, and plenty of them will be wondering whether the price moved too high, too fast.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

NasdaqGM:ARCT Earnings and Revenue Growth December 2nd 2020

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Arcturus Therapeutics Holdings stock, you should check out this free report showing analyst profit forecasts.

A Different Perspective

It's nice to see that Arcturus Therapeutics Holdings shareholders have gained 748% (in total) over the last year. That's better than the annualized TSR of 110% over the last three years. Given the track record of solid returns over varying time frames, it might be worth putting Arcturus Therapeutics Holdings on your watchlist. It's always interesting to track share price performance over the longer term. But to understand Arcturus Therapeutics Holdings better, we need to consider many other factors. For instance, we've identified 2 warning signs for Arcturus Therapeutics Holdings (1 can't be ignored) that you should be aware of.

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

When trading Arcturus Therapeutics Holdings or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

Valuation is complex, but we're helping make it simple.

Find out whether Arcturus Therapeutics Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis